Skip to content
lifestyle.brickvest.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Dermata Therapeutics
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the First Quarter 2026
May 26, 2026
Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Delivery System
May 20, 2026
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025
May 18, 2026
Dermata Announces Appointment of Kyra Peckaitis as Vice President, Marketing
May 16, 2026
Dermata Receives Notice of Grant of Patent for Next-Generation Acne Treatment by Australian Patent Office
January 20, 2026
Dermata Therapeutics Announces Closing of up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
December 29, 2025
Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
December 24, 2025